Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

5.80
Delayed Data
As of 4:00pm ET
 -0.09 / -1.53%
Today’s Change
5.67
Today|||52-Week Range
19.43
-57.26%
Year-to-Date

Today’s Trading

Previous close5.89
Today’s open5.84
Day’s range5.67 - 5.94
Volume1,038,553
Average volume (3 months)1,095,555
Market cap$512.9M
Dividend yield--
Data as of 4:00pm ET, 05/06/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book14.53

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc+2.81+12.48%
ANIPANI Pharmaceuticals ...-0.18-0.39%
RTRXRetrophin Inc-0.29-1.95%
CYADCelyad SA-0.43-0.87%
Data as of 4:00pm ET, 05/06/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs